Skip to content

Periodontal Disease in Patients With Lynch Syndrome

Periodontal Disease in Patients With Lynch Syndrome: a Retrospective Observational, Monocentric Case-control Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07600710
Acronym
SMILy_25
Enrollment
25
Registered
2026-05-22
Start date
2026-06-01
Completion date
2026-07-31
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lynch Syndrome, Periodontal Disease

Brief summary

The field of human microbiome research has undergone a revolution in its approach toward understanding how microorganisms influence the physiology of their host 1. The influence of the oral microbiota is not confined to this location 2. Periodontitis is a "chronic inflammatory disease associated with dysbiotic plaque biofilms and characterized by a progressive destruction of the tooth supporting apparatus"3. Given these observations, the central research question of the present study is to determine the prevalence of periodontitis in patients with Lynch syndrome (LS) compared with reference prevalence estimates from the general population40.

Interventions

OTHERperiodontal charting for the diagnosis of periodontitis

No additional interventions

Sponsors

Rotundo Roberto
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

1. Age ≥18 years; 2. All sexes eligible 3. Established diagnosis of LS performed as part of clinical practice, with a germline pathogenic/likely pathogenic variant in one of the following genes: MLH1, MSH2, MSH6, PMS2, and EpCAM 4. LS subjects undergoing surveillance gastrointestinal endoscopy according to clinical practice and international guidelines. 5. Subjects underwent dental and periodontal examination

Exclusion criteria

1. Age \< 18 years; 2. Absence of sufficient periodontal clinical or radiographic data to establish a periodontal diagnosis; 3. Subjects affected by systemic, autoimmune, chronic inflammatory, neurological, or severe psychiatric disorders, or by any other clinical condition that may interfere with study participation or data interpretation 4. Subjects with systemic conditions known to strongly affect periodontal status (e.g. uncontrolled diabetes, autoimmune inflammatory diseases, ongoing cancer therapy) were excluded to reduce major confounding factors that could independently alter periodontal outcomes.

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of periodontitis in Lynch Syndrome subjects.Retrospective assessment at study enrollmentDiagnosis of periodontitis * Interdental clinical attachment loss (CAL) at ≥2 non-adjacent teeth * Buccal/oral CAL ≥3 mm with pocketing \>3 mm detectable at ≥2 teeth Clinical attachment loss = CAL = Distance between the cementoenamel junction and the base of the periodontal pocket (tip of the periodontal probe)

Countries

Italy

Contacts

CONTACTProfessor Rotundo Roberto
rotundo.roberto@hsr.it0201751500

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026